- Home
- AUID vs TPST Comparison
AUID vs TPST Comparison
Compare AUID & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUID
- TPST
- Stock Information
- Founded
- AUID 2009
- TPST 2011
- Country
- AUID United States
- TPST United States
- Employees
- AUID N/A
- TPST N/A
- Industry
- AUID Computer Software: Prepackaged Software
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- AUID Technology
- TPST Health Care
- Exchange
- AUID Nasdaq
- TPST Nasdaq
- Market Cap
- AUID 47.3M
- TPST 45.5M
- IPO Year
- AUID N/A
- TPST N/A
- Fundamental
- Price
- AUID $2.95
- TPST $9.58
- Analyst Decision
- AUID
- TPST Hold
- Analyst Count
- AUID 0
- TPST 3
- Target Price
- AUID N/A
- TPST $30.00
- AVG Volume (30 Days)
- AUID 49.0K
- TPST 54.6K
- Earning Date
- AUID 11-06-2025
- TPST 11-11-2025
- Dividend Yield
- AUID N/A
- TPST N/A
- EPS Growth
- AUID N/A
- TPST N/A
- EPS
- AUID N/A
- TPST N/A
- Revenue
- AUID $2,189,524.00
- TPST N/A
- Revenue This Year
- AUID N/A
- TPST N/A
- Revenue Next Year
- AUID N/A
- TPST N/A
- P/E Ratio
- AUID N/A
- TPST N/A
- Revenue Growth
- AUID 295.86
- TPST N/A
- 52 Week Low
- AUID $2.74
- TPST $5.35
- 52 Week High
- AUID $9.58
- TPST $20.67
- Technical
- Relative Strength Index (RSI)
- AUID 34.12
- TPST 47.99
- Support Level
- AUID $2.74
- TPST $9.90
- Resistance Level
- AUID $3.14
- TPST $11.02
- Average True Range (ATR)
- AUID 0.38
- TPST 0.62
- MACD
- AUID -0.12
- TPST -0.20
- Stochastic Oscillator
- AUID 11.08
- TPST 4.78
About AUID authID Inc.
AuthID Inc is a company engaged in ensuring cyber-savvy enterprises Know Who's Behind the Device, for every customer or employee login and transaction. Through its easy-to-integrate, patented, biometric identity platform, authID quickly and accurately verifies a user's identity, eliminating any assumption of who is behind a device and preventing cybercriminals from taking over accounts. authID combines digital onboarding, biometric password less authentication and account recovery, with a fast, accurate, user-friendly experience-delivering identity verification.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.